Macular Telangiectestia Type 2

A Natural History Observation and Registry Study
of Macular Telangiectasia Type 2 (MacTel)
MEEI Protocol Number
National Clinical Trial (NCT) Number
Macular Telangiectasia Type 2
The Lowy Medical Research Institute
Principal Investigator
Joan Miller, M.D.
Study Design
Prospective Registry (database)
Study Objective
To enhance the understanding of the natural history and progression of Macular Telangiectasia Type 2 including possible genetic risk factors and to establish a registry of patients for future studies
Who is Eligible
Patients with Macular Telangiectasia Type 2 and their family members
Subject Enrollment
We are currently enrolling individuals with Macular Telangiectasia Type 2
Study Procedures
Subjects will be asked to provide a blood specimen for genetic testing and to determine if they have Macular Telangiectasia Type 2. Subjects are seen for one clinic visit only.
For More Information Ophthalmology Clinical Research Office

Click here to return to the Ophthalmology Clinical Research page.